If you made any changes in Pure these will be visible here soon.

Research Output

  • 8 Article
  • 1 Comment/Letter to the editor
  • 1 Doctoral Thesis
2019

A real-life study on the implementation and effectiveness of exemestane plus everolimus per hospital type in patients with advanced breast cancer. A study of the Southeast Netherlands Advanced Breast Cancer registry

Knapen, L. M., Geurts, S. M. E., Ibragimova, K. I. E., Croes, S., Vriens, B. E. P. J., van den Berkmortel, F. W. P. J., Dercksen, M. W., van de Wouw, A. J., Pepels, M. J. A. E., de Fallois, A. O. J., Lobbezoo, D. J. A., de Boer, M. & Tjan-Heijnen, V. C. G., Apr 2019, In : Breast. 44, p. 46-51 6 p.

Research output: Contribution to journalArticleAcademicpeer-review

Insight in disease and drug interactions, with treatment optimisation of patients with cancer

Knapen, L., 2019, Maastricht: Gildeprint Drukkerijen. 183 p.

Research output: ThesisDoctoral ThesisInternal

Open Access
File
275 Downloads (Pure)
2018

Administration of crizotinib via jejunostomy tube: A case report

Knapen, L., Dingemans, A-M. & Croes, S., 2018, In : OA Journal of Clinical Case Reports. 1, 3 p., 005.

Research output: Contribution to journalArticleAcademic

Open Access

Clinical validation study of dried blood spot for determining everolimus concentration in patients with cancer

Willemsen, A. E. C. A. B., Knapen, L. M., de Beer, Y. M., Bruggemann, R. J. M., Croes, S., van Herpen, C. M. L. & van Erp, N. P., 1 Apr 2018, In : European Journal of Clinical Pharmacology. 74, 4, p. 465-471 7 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Development and validation of an analytical method using UPLC-MS/MS to quantify everolimus in dried blood spots in the oncology setting

Knapen, L. M., de Beer, Y., Bruggemann, R. J. M., Stolk, L. M., de Vries, F., Tjan-Heijnen, V. C. G., van Erp, N. P. & Croes, S., 5 Feb 2018, In : Journal of Pharmaceutical and Biomedical Analysis. 149, p. 106-113 8 p.

Research output: Contribution to journalArticleAcademicpeer-review

The Impact of Dose and Simultaneous Use of Acid-Reducing Agents on the Effectiveness of Vemurafenib in Metastatic BRAF V600 Mutated Melanoma: a Retrospective Cohort Study

Knapen, L. M., Koornstra, R. H. T., Driessen, J. H. M., van Vlijmen, B., Croes, S., Schalkwijk, S., Colbers, A., Gerritsen, W. R., Burger, D. M., de Vries, F. & van Erp, N. P., Jun 2018, In : Targeted Oncology. 13, 3, p. 363-370 8 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access
2017

Fracture risk reduction with use of dipeptidyl peptidase-4 inhibitors: is there immortal time bias?

Driessen, J. H. M., Knapen, L. M., Geusens, P. P. M. M. & van den Bergh, J. P. W., Aug 2017, In : Osteoporosis International. 28, 8, p. 2429-2430 2 p.

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Use of incretin agents and risk of acute and chronic pancreatitis: A population-based cohort study

Knapen, L. M., de Jong, R. G. P. J., Driessen, J. H. M., Keulemans, Y. C., van Erp, N. P., De Bruin, M. L., Leufkens, H. G. M., Croes, S. & de Vries, F., Mar 2017, In : Diabetes Obesity & Metabolism. 19, 3, p. 401-411 11 p.

Research output: Contribution to journalArticleAcademicpeer-review

2016

Het gebruik van incretines en het risico op alvleesklierkanker: een populatiegebaseerde cohortstudie

Knapen, L., van Erp, N. P., Leufkens, H. G. M., Croes, S., de Vries, F. & Driessen, J. H. M., 2016, In : Nederlands Platform voor Farmaceutisch Onderzoek. 1, a1627.

Research output: Contribution to journalArticleAcademicpeer-review

Use of incretin agents and risk of pancreatic cancer: a population-based cohort study

Knapen, L., van Dalem, J., Keulemans, J., van Erp, N. P., Bazelier, M. T., de Bruin, M. L., Leufkens, H. G., Croes, S., Neef, C., de Vries, F. & Driessen, J. H. M., Mar 2016, In : Diabetes Obesity & Metabolism. 18, 3, p. 258-265 8 p.

Research output: Contribution to journalArticleAcademicpeer-review

5 Citations (Scopus)